Injectable Drugs Market Growth: Projected to Reach US$9.92 Billion by 2034 at a 5.8% CAGR | FMI

Posted on 2024-06-18 by Future Market Insights in Healthcare, Pharmaceuticals // 0 Comments

The Injectable Drugs Market is poised for a steady and significant rise, fueled by the growing demand for convenient and effective treatment options. A recent assessment revealed a robust market size of US$5.98 billion in 2024. This momentum is expected to continue, with the market projected to climb at a compelling Compound Annual Growth Rate (CAGR) of 5.8% over the next decade. By 2034, the market is anticipated to reach a staggering US$9.92 billion, signifying a promising future for this vital segment of the healthcare industry.

Advancements in technologies that involve optimization of the devices used for clinical conditions, be it chronic or acute, clinical innovations, bringing in minimally invasive treatments, and evolvement in clinical diagnostics and management in treating high-risk patients, are the key developments within the general healthcare industry.

Request a Sample PDF using a Work Email To Get a Quick Reply!
https://www.futuremarketinsights.com/reports/sample/rep-gb-15073

Demand for related treatments is increasing, as people are now more aware of the right treatment options, doctor-guided plans, and precautionary measures to consider for serious clinical conditions.

Key players in the injectable drugs market are actively seeking to gain approvals from regulatory bodies and develop products across the continuum of care in severe case recovery. Furthermore, the FDA is expected to approve new devices related to advanced injectable drugs and their administration, over the coming years.

“Increasing incidence of infectious diseases, oncological diseases, cardiac disorders and device innovation are prompting healthcare providers to incorporate new treatment regimens for improved patient outcome,” says an FMI analyst.

Injectable Drugs Market Key Takeaways:

By product, monoclonal antibodies held the largest share of 5% in the global market in 2021.
Based on application, the infectious diseases segment held the largest share of 4% in the global market in 2021, with the segment expected to expand at 5.7% CAGR over the forecast period.
In terms of molecules, the large molecule segment held the largest share of 8% in the global market in 2021.
By route of administration, sales in the intravenous (IV) segment are expected to increase at a 3% CAGR over the assessment period.
Based on the distribution channel, the hospital pharmacies segment was valued at US$ 231.0 Bn in 2021.
North America held the largest share of 5% in the global injectable drugs treatment market in 2021, owing to the growing government investments in healthcare and R&D activities.

Injectable Drugs Market Competitive Landscape

Product launches and collaborations with suppliers that have a strong position and are popular in the market are some of the key strategies of the market players operating in the global injectable drugs market. For instance:

Merck and Gilead Sciences, Inc. (Gilead) signed an agreement in March 2021 to collaborate on the development and commercialization of long-acting HIV treatments that combine Merck’s investigational nucleoside reverse transcriptase translocation inhibitor islatravir and Gilead’s investigational capsid inhibitor lenacapavir.
In March 2022, Sanofi IGM Biosciences, Inc. today announced the signing of an exclusive worldwide collaboration agreement to create, develop, manufacture, and commercialize IgM antibody agonists against three oncology targets and three immunology/inflammation targets. Engineered IgM antibodies represent a new class of potential therapeutics that combine the multi-valency of IgM antibodies possessing 10 binding sites compared to conventional IgG antibodies having only 2 target binding sites.
In February 2022, Novartis India Limited extended access to its medicines in India by signing an exclusive sales and distribution agreement with Dr. Reddy’s Laboratories

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the injectable drugs market in its latest study, presenting a historical demand assessment of 2014 – 2021 and projections for 2022 – 2032.

The research study is based on the product – (monoclonal antibodies, immunoglobulin, cytokines, insulin, peptide hormones, blood factors, peptide antibiotics, vaccines, small molecule antibiotics, chemotherapy agents, and others), by application (oncology, infectious diseases, diabetes, blood disorders, hormonal disorders, musculoskeletal disorders, CNS diseases, pain management, and cardiovascular diseases), by molecule type (small molecules and large molecules), by route of administration (intravenous (IV), intramuscular (IM), and subcutaneous (SC)), by distribution channel (hospital pharmacies, retail pharmacies, drug stores, and online pharmacies), across seven key regions of the world.

Purchase The Full Report Here
https://www.futuremarketinsights.com/checkout/15073

Injectable Drugs Market Key Players :

Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Sanofi S.A.
Sun Pharmaceutical Industries Ltd.
AstraZeneca Plc
Merck & Co., Inc.
Viatris + Mylan N.V
Cipla Inc.
Dr. Reddy’s Laboratories Ltd.
Samsung Biologics
Abbott Laboratories
Amgen Incorporated
Baxter International Incorporated
Becton Dickinson and Company
Bristol-Myers Squibb Company
GlaxoSmithKline Plc
Roche Holding Limited

Key Segments Covered in Injectable Drugs Market Research

By Product:

Monoclonal Antibodies
Immunoglobulin
Cytokines
Insulin
Peptide Hormones
Blood Factors
Peptide Antibiotics
Vaccines
Small Molecule Antibiotics
Chemotherapy Agents
Others

By Application:

Oncology
Infectious Diseases
Diabetes
Blood disorders
Hormonal Disorders
Musculoskeletal Disorders
CNS Diseases
Pain Management
Cardiovascular Diseases

By Molecule Type:

Small Molecules
Large Molecules

By Route of Administration:

Intravenous (IV)
Intramuscular (IM)
Subcutaneous (SC)

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Pharmacies

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Matched content

Editor’s pick